Page values for "Hydroxychloroquine"
From Pharmacopedia
More actions
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Hydroxychloroquine |
| brand | String | Plaquenil; mostly prescribed generically |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Antimalarials|Antimalarial (4-aminoquinoline)]] • [[:Category:DMARDs|DMARD]] • [[:Category:Immunomodulators|Immunomodulator]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-000007E7-QINU`"', '"`UNIQ--vote-000007E8-QINU`"', '"`UNIQ--vote-000007E9-QINU`"', '"`UNIQ--vote-000007EA-QINU`"', '"`UNIQ--vote-000007EB-QINU`"' |
| starting_dose | String | 200-400 mg PO daily; '''dose by actual body weight ≤5 mg/kg/d''' to reduce retinopathy risk (AAO 2016 guideline) |
| preparations | String | 200 mg tablets; 100 mg/5 mL suspension |
| fda_max | String | 400 mg/d typical maintenance; weight-adjusted ceiling per ophthalmology guidance |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | Rheumatologic effect at 6-12 weeks |
| duration | String | Weeks (long half-life) |
| halflife | String | ~40 days (terminal; reflects extensive tissue distribution)'"`UNIQ--ref-000007EC-QINU`"' |
| bioavailability | String | 70-75% (oral)'"`UNIQ--ref-000007ED-QINU`"' |
| pregnancy | String | Long-considered safe in pregnancy for lupus and other rheumatologic indications; benefits typically outweigh.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |